New England Journal of Medicine· 2015Q1· Review
Acute Myeloid Leukemia
- 3,393citations
- Q1SCImago
- 2015year
Short summary
Recent biological discoveries in acute myeloid leukemia (AML) have deepened our understanding of its classification, though these insights have yet to significantly alter current treatment approaches.
AI-generated from the title and abstract; the full text is not read.
Key points
- New biological insights have clarified the classification of acute myeloid leukemia (AML).
- These advancements have not yet led to major changes in AML treatment.
- Investigational strategies are being explored to potentially improve patient outcomes.
AI-generated from the title and abstract; the full text is not read.
Abstract
Many recent biologic insights have shed light on the nosology of acute myeloid leukemia. Although this new knowledge has not yet had a major influence on the treatment of the disease, strategies under investigation may improve outcomes.
The authors' abstract, as published at the source. New England Journal of Medicine, 2015 · DOI ↗
Continue with a free account
Ask the paper: 3 free questions a day about this paper; save it, get its citation, new summaries every day for your field. Takeaways are Premium.
Continue free on the webSign in with Google or Apple; no card needed. You come back to this paper.
On your phone:
Field: Hematology
HematologyMedicine